VSEE

SCHEDULE 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

8-K - VSEE HEALTH, INC. (0001864531) (Filer)

8-K - VSEE HEALTH, INC. (0001864531) (Filer)

The acquisition is expected to close fairly quickly and without any initial shareholder dilution HOUSTON, TX / ACCESS Newswire / July 30, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth technology and digital health solutions, today announced that it has entered into a non-binding letter of intent (the "LOI") for the proposed acquisition of certain healthcare technology and operating assets. The contemplated assets support an integrated healthcare commerce platform serving the United States clinic-based wellness market. The current annual run rate for the target assets is in excess of $35 million, and EBITDA is approximately $7 million (both

Proposed acquisition, valued at $42 million, could add over $35 million in annualized revenue and more than $7 million in earnings HOUSTON, TX / ACCESS Newswire / July 29, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth technology and digital health solutions, today announced that it has entered into a non-binding letter of intent (the "LOI") for the proposed acquisition of certain healthcare technology and operating assets. The contemplated assets support an integrated healthcare commerce platform serving the United States clinic-based wellness market. The current annual run rate for the target assets is in excess of $35 million, and EBITDA

HOUSTON, TX / ACCESS Newswire / July 28, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today announced that its Board of Directors has initiated a comprehensive strategic review aimed at pursuing transformational opportunities to accelerate growth and maximize shareholder value.The Board believes VSee has reached an important inflection point. Over the past year, the Company has strengthened its operating foundation, enhanced its technology platform and continued to expand its position in the rapidly evolving digital healthcare market. As a result, the Board believes this is the appropriate time to evaluate st

8-K - VSEE HEALTH, INC. (0001864531) (Filer)

HOUSTON, TX / ACCESS Newswire / July 22, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today reaffirmed its commitment to protecting shareholder value by minimizing dilution while maintaining the financial flexibility needed to execute its growth strategy. Our Board of Directors has approved a proposed maximum of an 80-for-1 reverse stock split, subject to the completion of all applicable regulatory requirements and shareholder approvals. This action is intended to better align our capital structure with our long-term strategic objectives and support our continued Nasdaq listing. The company wants to affirm wi

DEF 14A - VSEE HEALTH, INC. (0001864531) (Filer)

VSEE's Telehealth Platform is Positioned at the Center of Healthcare's AI Transformation HOUSTON, TX / ACCESS Newswire / July 14, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of enterprise telehealth solutions for hospitals and health systems, today shared its strategic initiatives and perspective on the role of artificial intelligence in healthcare and why enterprise telehealth platforms are well positioned to serve as the infrastructure layer for that transformation."We believe healthcare is entering a new technology cycle in which artificial intelligence becomes an operating layer, rather than simply another application," said Dr. Imoigele Aisiku, C

PRE 14A - VSEE HEALTH, INC. (0001864531) (Filer)

8-K - VSEE HEALTH, INC. (0001864531) (Filer)

HOUSTON, TX / ACCESS Newswire / July 9, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today issued the following letter from Chairman and Chief Executive Officer Dr. Imoigele Aisiku providing shareholders with an update on the Company's strategic transformation and outlook.Dear Fellow Shareholders,Over the past two years, VSee Health has undergone a significant transformation. Our objective has been straightforward: simplify the Company, strengthen our operating business, improve our financial profile and position VSee for long-term growth. Today, I would like to update you on several important milestones that

8-K - VSEE HEALTH, INC. (0001864531) (Filer)

424B3 - VSEE HEALTH, INC. (0001864531) (Filer)

8-K - VSEE HEALTH, INC. (0001864531) (Filer)

Key Driver for its Enterprise Telehealth Revenue Acceleration HOUSTON, TX / ACCESS Newswire / June 25, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, is pleased to announce that its hospital footprint has grown to 58 locations, up from just 3 in approximately two tears. This dramatic ramp of 20-fold over the past two years, has led to a significant +80% growth in revenue in 2025 to $11.4 million.This growth in the VSee hospital network has been driven by expanding Integrated Delivery Network relationships and multi-year deployments.VSee Health Chairman and Chief Executive Officer Dr. Imoigele Aisiku commented,

Refocus on Telehealth and Digital Health Solutions That Provided 80% Revenue Growth in 2025 HOUSTON, TX / ACCESS Newswire / June 22, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solution, is pleased to provide an update on its business operations and financial success following its strategic sale of VSee Lab on May 31, 2026.Pro-forma financials from enhanced focus on iDoc telehealth platform and enterprise healthcare solutions:+60% revenue growth to $8 million in 2025+70% revenue growth to $2.5 million in Q1 2026Approximate reduction of $6.0 million in annual operating expensesSeveral large IDN (Integrated Health Networ

HOUSTON, TX / ACCESS Newswire / June 11, 2026 / VSee Health, Inc. (NASDAQ:VSEE) today announced the completion of a transformative strategic transaction that separates the Company from its former laboratory subsidiary, VSee Lab, eliminates a significant block of outstanding shares, and positions VSee Health to focus exclusively on its core telehealth and digital health platform businesses.Under a Stock Purchase Agreement dated May 31, 2026, VSee Health sold 100% of VSee Lab, Inc. to former Co-Chief Executive Officer and Chairman Milton Chen. In connection with the transaction, Mr. Chen transferred all 2,870,069 shares of VSee Health common stock owned by him back to the Company and assumed r

424B3 - VSEE HEALTH, INC. (0001864531) (Filer)

8-K - VSEE HEALTH, INC. (0001864531) (Filer)

4 - VSEE HEALTH, INC. (0001864531) (Issuer)

424B3 - VSEE HEALTH, INC. (0001864531) (Filer)

10-Q - VSEE HEALTH, INC. (0001864531) (Filer)

SCHEDULE 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)